HBV and Targeted Synthetic (Ts)DMARDs: What Have We Learned From bDMARDs and tsDMARDs?

RMD Open - United Kingdom
doi 10.1136/rmdopen-2020-001171
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

What We Have Learned From Ribosome Structures

Biochemical Society Transactions
Biochemistry
2008English

EuReCa_Serbia: What Have We Learned?

Journal Resuscitatio Balcanica
2019English

What We Have Learned and How We May Proceed

International Studies in Entrepreneurship
2020English

Harness the Synergy Between Targeted Therapy and Immunotherapy: What Have We Learned and Where Are We Headed?

Oncotarget
Oncology
2017English

What Have We Learned, So Far?

Prehospital and Disaster Medicine
Emergency NursingEmergency Medicine
2002English

Attention Deficits and Hyperactivity–impulsivity: What Have We Learned, What Next?

Development and Psychopathology
PsychiatryDevelopmentalMental HealthEducational Psychology
2013English

The RCS ESOS Course: What Have We Learned and What Have We to Offer Other Course Organisers?

The Bulletin of the Royal College of Surgeons of England
2011English

Entry and Fireball Models vs. Observations: What Have We Learned?

International Astronomical Union Colloquium
1996English

Two Decades of IDPs; What Have We Learned?

Biophysical Journal
Biophysics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy